Skip to content

PL   |   EN   |   RU

Biały logotyp Stockholm 3

Prostate cancer is the most common cancer and the second leading cause of cancer-related deaths among men in Poland.

Each year, more than 5,000 patients die due to prostate cancer being detected too late. It doesn’t have to be this way.

At last. A genetic test that changes everything. The Stockholm3 test. A simple blood draw.

When detected early, prostate cancer offers a 100% chance of cure (5-year survival).

The Stockholm3 test identifies risk at an early stage, allowing appropriate action to be taken in time.

Coming soon to Poland.